JP5912077B2 - スパイダーシルクタンパク質の重合体を産生する方法 - Google Patents
スパイダーシルクタンパク質の重合体を産生する方法 Download PDFInfo
- Publication number
- JP5912077B2 JP5912077B2 JP2012507182A JP2012507182A JP5912077B2 JP 5912077 B2 JP5912077 B2 JP 5912077B2 JP 2012507182 A JP2012507182 A JP 2012507182A JP 2012507182 A JP2012507182 A JP 2012507182A JP 5912077 B2 JP5912077 B2 JP 5912077B2
- Authority
- JP
- Japan
- Prior art keywords
- spider silk
- amino acid
- silk protein
- protein
- acid residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims description 362
- 102000004169 proteins and genes Human genes 0.000 title claims description 352
- 229920001872 Spider silk Polymers 0.000 title claims description 233
- 229920000642 polymer Polymers 0.000 title claims description 117
- 238000004519 manufacturing process Methods 0.000 title claims description 26
- 238000006116 polymerization reaction Methods 0.000 claims description 138
- 125000000539 amino acid group Chemical group 0.000 claims description 131
- 239000012634 fragment Substances 0.000 claims description 130
- 239000007788 liquid Substances 0.000 claims description 113
- 239000000203 mixture Substances 0.000 claims description 84
- 238000000034 method Methods 0.000 claims description 66
- 239000000835 fiber Substances 0.000 claims description 46
- 210000004900 c-terminal fragment Anatomy 0.000 claims description 43
- 210000004898 n-terminal fragment Anatomy 0.000 claims description 41
- 150000007523 nucleic acids Chemical class 0.000 claims description 26
- 230000003252 repetitive effect Effects 0.000 claims description 24
- 239000002510 pyrogen Substances 0.000 claims description 16
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 239000010409 thin film Substances 0.000 claims description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 11
- 150000002500 ions Chemical class 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 5
- 230000000379 polymerizing effect Effects 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 235000018102 proteins Nutrition 0.000 description 292
- 239000002609 medium Substances 0.000 description 123
- 150000001413 amino acids Chemical class 0.000 description 58
- 210000004027 cell Anatomy 0.000 description 37
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 34
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 30
- 108010022355 Fibroins Proteins 0.000 description 29
- 230000015572 biosynthetic process Effects 0.000 description 27
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 27
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 22
- 239000002158 endotoxin Substances 0.000 description 20
- 229920006008 lipopolysaccharide Polymers 0.000 description 20
- 108020001507 fusion proteins Proteins 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 229920002684 Sepharose Polymers 0.000 description 17
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 17
- 230000004927 fusion Effects 0.000 description 17
- 102000037865 fusion proteins Human genes 0.000 description 17
- 230000003993 interaction Effects 0.000 description 17
- 239000011780 sodium chloride Substances 0.000 description 17
- 239000000872 buffer Substances 0.000 description 16
- 235000001014 amino acid Nutrition 0.000 description 15
- 229910019142 PO4 Inorganic materials 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 14
- 239000000539 dimer Substances 0.000 description 14
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 14
- 239000010452 phosphate Substances 0.000 description 14
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 14
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 13
- 239000006391 Luria-Bertani Medium Substances 0.000 description 13
- 229930027917 kanamycin Natural products 0.000 description 13
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 13
- 229960000318 kanamycin Drugs 0.000 description 13
- 229930182823 kanamycin A Natural products 0.000 description 13
- 102000016943 Muramidase Human genes 0.000 description 12
- 108010014251 Muramidase Proteins 0.000 description 12
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 12
- 210000004899 c-terminal region Anatomy 0.000 description 12
- 230000000875 corresponding effect Effects 0.000 description 12
- 239000013604 expression vector Substances 0.000 description 12
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 12
- 229960000274 lysozyme Drugs 0.000 description 12
- 239000004325 lysozyme Substances 0.000 description 12
- 235000010335 lysozyme Nutrition 0.000 description 12
- 239000006228 supernatant Substances 0.000 description 12
- 239000013598 vector Substances 0.000 description 12
- 241000328437 Euprosthenops australis Species 0.000 description 11
- 229920000136 polysorbate Polymers 0.000 description 11
- 238000000746 purification Methods 0.000 description 11
- 230000000903 blocking effect Effects 0.000 description 10
- 230000001419 dependent effect Effects 0.000 description 10
- 108091033319 polynucleotide Proteins 0.000 description 10
- 102000040430 polynucleotide Human genes 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 9
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 9
- 235000004279 alanine Nutrition 0.000 description 9
- 150000001720 carbohydrates Chemical class 0.000 description 9
- 235000014633 carbohydrates Nutrition 0.000 description 9
- 238000004090 dissolution Methods 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 239000004471 Glycine Substances 0.000 description 8
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 8
- 239000013592 cell lysate Substances 0.000 description 8
- 239000003446 ligand Substances 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 7
- 238000002296 dynamic light scattering Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000013636 protein dimer Substances 0.000 description 7
- 239000012736 aqueous medium Substances 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- RYVMUASDIZQXAA-UHFFFAOYSA-N pyranoside Natural products O1C2(OCC(C)C(OC3C(C(O)C(O)C(CO)O3)O)C2)C(C)C(C2(CCC3C4(C)CC5O)C)C1CC2C3CC=C4CC5OC(C(C1O)O)OC(CO)C1OC(C1OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OCC(O)C(O)C1O RYVMUASDIZQXAA-UHFFFAOYSA-N 0.000 description 6
- 108091035707 Consensus sequence Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 239000001488 sodium phosphate Substances 0.000 description 5
- 229910000162 sodium phosphate Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- 241000239290 Araneae Species 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- AXAVXPMQTGXXJZ-UHFFFAOYSA-N 2-aminoacetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(O)=O.OCC(N)(CO)CO AXAVXPMQTGXXJZ-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 238000001261 affinity purification Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000007026 protein scission Effects 0.000 description 3
- 235000004400 serine Nutrition 0.000 description 3
- 238000012807 shake-flask culturing Methods 0.000 description 3
- 238000000527 sonication Methods 0.000 description 3
- 108010028210 spidroin 1 Proteins 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 101710191900 Actin-depolymerizing factor 4 Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 101000612671 Homo sapiens Pulmonary surfactant-associated protein C Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 102100040971 Pulmonary surfactant-associated protein C Human genes 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 108010028203 spidroin 2 Proteins 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 101150082901 ADF3 gene Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000193935 Araneus diadematus Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241001529572 Chaceon affinis Species 0.000 description 1
- LVNMAAGSAUGNIC-BQBZGAKWSA-N Cys-His Chemical compound SC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 LVNMAAGSAUGNIC-BQBZGAKWSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000380914 Hesperus Species 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- 101150104297 MASP1 gene Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000282322 Panthera Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 101800001491 Protease 3C Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000005421 electrostatic potential Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229920000140 heteropolymer Polymers 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000003367 kinetic assay Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000011046 pyrogen test Methods 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09158445.8 | 2009-04-22 | ||
| EP09158445A EP2243792A1 (en) | 2009-04-22 | 2009-04-22 | Methods of producing polymers of spider silk proteins |
| EP10156927.5 | 2010-03-18 | ||
| EP10156923.4 | 2010-03-18 | ||
| EP10156923 | 2010-03-18 | ||
| EP10156927 | 2010-03-18 | ||
| PCT/SE2010/050439 WO2010123450A1 (en) | 2009-04-22 | 2010-04-21 | Method of producing polymers of spider silk proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012531889A JP2012531889A (ja) | 2012-12-13 |
| JP2012531889A5 JP2012531889A5 (cg-RX-API-DMAC7.html) | 2013-06-20 |
| JP5912077B2 true JP5912077B2 (ja) | 2016-04-27 |
Family
ID=43011348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507182A Active JP5912077B2 (ja) | 2009-04-22 | 2010-04-21 | スパイダーシルクタンパク質の重合体を産生する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8642734B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2421890B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5912077B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102395601A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010239773B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2759465C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2421890T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2560437C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010123450A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5726282B2 (ja) | 2010-03-18 | 2015-05-27 | スパイバー テクノロジーズ アーベーＳｐｉｂｅｒ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ａｂ | タンパク質及びポリペプチドの産生 |
| CA2815267C (en) | 2010-10-27 | 2019-06-25 | Spiber Technologies Ab | Spider silk fusion protein structures for binding to an organic target |
| US9617315B2 (en) | 2011-06-01 | 2017-04-11 | Spiber Inc. | Artificial polypeptide fiber and method for producing the same |
| CA2872056A1 (en) * | 2012-05-02 | 2013-11-07 | Spiber Technologies Ab | Spider silk fusion protein structures without repetitive fragment for binding to an organic target |
| ES2887366T3 (es) | 2013-09-17 | 2021-12-22 | Bolt Threads Inc | Métodos y composiciones para sintetizar fibras de seda mejoradas |
| AU2015358537B2 (en) | 2014-12-02 | 2021-08-19 | Evolved By Nature, Inc. | Silk performance apparel and products and methods of preparing the same |
| CN114000218A (zh) * | 2015-03-16 | 2022-02-01 | 保尔特纺织品公司 | 改善的丝纤维 |
| CN107849100B (zh) | 2015-04-09 | 2022-02-08 | 丝芭博株式会社 | 极性溶剂溶液及其制造方法 |
| JP6856828B2 (ja) | 2015-04-09 | 2021-04-14 | Ｓｐｉｂｅｒ株式会社 | 極性溶媒溶液及びその製造方法 |
| EP3307765B1 (en) * | 2015-06-11 | 2024-04-10 | Bolt Threads, Inc. | Recombinant protein fiber yarns with improved properties |
| CN105031723B (zh) * | 2015-06-23 | 2017-05-24 | 上海交通大学 | 基于蜘蛛丝蛋白的温敏性水凝胶 |
| BR112018000699B1 (pt) | 2015-07-14 | 2023-10-17 | Silk Therapeutics, Inc | Artigo e método para revestir um material |
| JP2018159137A (ja) | 2015-08-20 | 2018-10-11 | 国立研究開発法人理化学研究所 | クモ糸様構造を有するポリペプチド繊維の製造方法 |
| EP3374378B1 (en) | 2015-11-13 | 2021-02-17 | Spiber Technologies AB | Charge-reversed n-terminal spider silk protein domain and uses thereof |
| GB201522610D0 (en) * | 2015-12-22 | 2016-02-03 | Univ Southampton | Protein |
| WO2017198655A1 (en) * | 2016-05-16 | 2017-11-23 | Spiber Technologies Ab | Spider silk coating of solid surfaces |
| JP2019518882A (ja) * | 2016-06-10 | 2019-07-04 | ボルト スレッズ インコーポレイテッド | 改善された特性を有する組換えタンパク質繊維糸 |
| EP3263593A1 (en) | 2016-07-01 | 2018-01-03 | Anna Rising | Engineered spider silk proteins and uses thereof |
| KR20190046993A (ko) | 2016-09-14 | 2019-05-07 | 볼트 쓰레즈, 인크. | 긴 균일한 재조합 단백질 섬유 |
| US20190275193A1 (en) * | 2016-11-11 | 2019-09-12 | Amsilk Gmbh | Use of a shrinkable biopolymer fiber as a sensor |
| CN107475807A (zh) * | 2017-08-30 | 2017-12-15 | 常州豫春化工有限公司 | 一种改性尼龙6纤维的制备方法 |
| KR102609621B1 (ko) * | 2017-09-26 | 2023-12-01 | 스파이버 테크놀러지스 에이비 | 표면 활성 거대분자의 구조화 |
| EP3688018A4 (en) | 2017-09-27 | 2021-07-07 | Evolved by Nature, Inc. | SILK COVERED FABRICS, RELATED PRODUCTS AND PREPARATION PROCESSES |
| JP2021035330A (ja) * | 2017-09-29 | 2021-03-04 | Ｓｐｉｂｅｒ株式会社 | 発現カセット |
| BR112021026217A2 (pt) * | 2019-07-04 | 2022-02-15 | Seevix Mat Sciences Ltd | Sistema de expressão procariótica e métodos de uso do mesmo. |
| CN110551194B (zh) * | 2019-09-19 | 2023-03-21 | 天津大学 | 重组蜘蛛卵鞘丝蛋白复合物及其生成的人造卵鞘丝 |
| BR112022020937A2 (pt) | 2020-04-23 | 2022-12-20 | Seevix Mat Sciences Ltd | Composições cosméticas compreendendo seda de aranha dragon sintética. |
| WO2024091831A2 (en) * | 2022-10-28 | 2024-05-02 | National Taiwan University | A recombinant spider silk protein and method for tag-free and time-saving purification thereof |
| CN218413490U (zh) | 2022-10-31 | 2023-01-31 | 徐州龙安电子科技有限公司 | 一种新型蜘蛛电子标签 |
| DE102023105437B3 (de) | 2023-03-06 | 2024-06-13 | Dr. Ing. H.C. F. Porsche Aktiengesellschaft | Fahrzeugkomponente mit wenigstens einer Fahrzeuginnenraumkomponente |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070260039A1 (en) | 2002-01-11 | 2007-11-08 | Karatzas Costas N | Methods of Producing Silk Polypeptides and Products Thereof |
| CN101018806B (zh) * | 2004-07-22 | 2014-05-07 | Am丝绸有限责任公司 | 重组蜘蛛丝蛋白 |
| RU2444527C2 (ru) * | 2005-12-30 | 2012-03-10 | Спибер Текнолоджиз Аб | Рекомбинантный спидроиновый белок главной ампулярной железы, способный к полимеризации, рекомбинантный слитый белок, способный к управляемой полимеризации, полимер спидроинового белка главной ампулярной железы, композиция для управляемой полимеризации, рекомбинантная молекула нуклеиновой кислоты (варианты), способ получения растворимого слитого белка, способ получения полимера спидроинового белка главной ампулярной железы и способ культивирования эукариотических клеток |
| BRPI0701826B1 (pt) * | 2007-03-16 | 2021-02-17 | Embrapa - Empresa Brasileira De Pesquisa Agropecuária | proteínas da teia de aranha nephilengys cruentata, avicularia juruensis e parawixia bistriata isoladas da biodiversidade brasileira |
| US9051383B2 (en) * | 2007-06-11 | 2015-06-09 | The Regents Of The University Of California | Spider silk dragline polynucleotides, polypeptides and methods of use thereof |
-
2010
- 2010-04-21 DK DK10767397.2T patent/DK2421890T3/en active
- 2010-04-21 US US13/264,938 patent/US8642734B2/en active Active
- 2010-04-21 CA CA2759465A patent/CA2759465C/en not_active Expired - Fee Related
- 2010-04-21 CN CN2010800169433A patent/CN102395601A/zh active Pending
- 2010-04-21 WO PCT/SE2010/050439 patent/WO2010123450A1/en not_active Ceased
- 2010-04-21 AU AU2010239773A patent/AU2010239773B2/en not_active Ceased
- 2010-04-21 JP JP2012507182A patent/JP5912077B2/ja active Active
- 2010-04-21 EP EP10767397.2A patent/EP2421890B1/en active Active
- 2010-04-21 RU RU2011145429/10A patent/RU2560437C2/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012531889A (ja) | 2012-12-13 |
| RU2560437C2 (ru) | 2015-08-20 |
| AU2010239773A1 (en) | 2011-11-03 |
| EP2421890A4 (en) | 2012-10-24 |
| WO2010123450A1 (en) | 2010-10-28 |
| CA2759465A1 (en) | 2010-10-28 |
| US20120041177A1 (en) | 2012-02-16 |
| EP2421890B1 (en) | 2015-08-26 |
| AU2010239773B2 (en) | 2014-11-06 |
| CA2759465C (en) | 2017-12-12 |
| CN102395601A (zh) | 2012-03-28 |
| EP2421890A1 (en) | 2012-02-29 |
| US8642734B2 (en) | 2014-02-04 |
| RU2011145429A (ru) | 2013-05-27 |
| DK2421890T3 (en) | 2015-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5912077B2 (ja) | スパイダーシルクタンパク質の重合体を産生する方法 | |
| RU2444527C2 (ru) | Рекомбинантный спидроиновый белок главной ампулярной железы, способный к полимеризации, рекомбинантный слитый белок, способный к управляемой полимеризации, полимер спидроинового белка главной ампулярной железы, композиция для управляемой полимеризации, рекомбинантная молекула нуклеиновой кислоты (варианты), способ получения растворимого слитого белка, способ получения полимера спидроинового белка главной ампулярной железы и способ культивирования эукариотических клеток | |
| JP5726282B2 (ja) | タンパク質及びポリペプチドの産生 | |
| JP5128943B2 (ja) | 組換えスパイダーシルクタンパク質 | |
| US10899803B2 (en) | Compounds and methods for the production of suckerin and uses thereof | |
| EP2243792A1 (en) | Methods of producing polymers of spider silk proteins | |
| EP2844361B1 (en) | Spider silk fusion protein structures incorporating immunoglobulin fragments as affinity ligands | |
| CN104936979A (zh) | 多肽颗粒及其制造方法 | |
| EP2844360B1 (en) | Spider silk fusion protein structures without repetitive fragment for binding to an organic target | |
| CN111094326A (zh) | 用于产生丝融合蛋白的浓缩粘合相的方法 | |
| CN113372428B (zh) | 文昌鱼C型凝集素BjCTL4基因及其应用 | |
| Hekman | Production of Synthetic Spider Silk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130419 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130419 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140902 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20141201 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20141208 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20141222 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150130 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150302 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150908 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160108 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160120 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20160210 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160301 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160331 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5912077 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |